The only thing that concerns me is that the quarterly was the same as last quarter.....word for word.....they might repeat that in the next quarter, looking into IT and Biotech projects/acquisitions.
- Forums
- ASX - By Stock
- FEX
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-68
Featured News
Add FEX (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $190.9M |
Open | High | Low | Value | Volume |
26.0¢ | 26.5¢ | 26.0¢ | $499.4K | 1.910M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 2102866 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 174750 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 2102866 | 0.260 |
6 | 220000 | 0.255 |
27 | 531655 | 0.250 |
15 | 494345 | 0.245 |
14 | 466367 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 174750 | 6 |
0.270 | 213586 | 6 |
0.275 | 319941 | 5 |
0.280 | 234281 | 9 |
0.285 | 206513 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
FEX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online